Topics

GM-CSF as a Therapeutic Target in Psoriasis

08:00 EDT 8 Jul 2019 | Medscape

This study investigated whether namilumab, a granulocyte-macrophage colony-stimulating factor inhibitor, might improve outcomes in patients with moderate or severe plaque psoriasis.
The British Journal of Dermatology

Original Article: GM-CSF as a Therapeutic Target in Psoriasis

NEXT ARTICLE

More From BioPortfolio on "GM-CSF as a Therapeutic Target in Psoriasis"

Quick Search

Relevant Topic

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...